MSMSD Partners, L.P.

Institutional investor · Portfolio as of Q1 2025

Top Holdings9 positions

Checking export access…
Activity:

ODDITY TECH LTD

1.8M$77.1M57.3%$28.35+51.46%
7 qtrssince 2023-Q3
Unchanged
0

HAYWARD HLDGS INC

1.3M$18.7M13.9%$16.58-16.76%
13 qtrssince 2022-Q1
Unchanged
0

XPONENTIAL FITNESS INC

1.7M$13.8M10.3%$14.45-46.66%
12 qtrssince 2022-Q2
Increased
67

RENEW ENERGY GLOBAL PLC

2.1M$12.3M9.2%$7.78-24.29%
14 qtrssince 2021-Q4
Unchanged
0
SAFESAFE
REIT

Safehold Inc

222,644$4.2M3.1%$24.45-28.93%
9 qtrssince 2023-Q1
Unchanged
0
EEXEEXDelisted

EMERALD HOLDING INC

1.1M$4.1M3.1%——
2 qtrssince 2024-Q4
Increased
82
OPITQOPITQDelisted
REIT

OFFICE PPTYS INCOME TR

5.1M$2.3M1.7%——
2 qtrssince 2024-Q4
Unchanged
0

SERVICETITAN INC

18,388$1.7M1.3%$102.87-7.54%
2 qtrssince 2024-Q4
Unchanged
0

TRISALUS LIFE SCIENCES INC

39,999$220,7940.2%$4.61+19.74%
3 qtrssince 2024-Q3
Unchanged
0
$134.5M
AUM
9
Positions
Q1 2025
Filing
HI score · 1.5/5
Quarterly 13F Value Change
-5%Q4'23$1.2B+6%Q1'24$1.2B-18%Q2'24$1B-85%Q3'24$157.7M-10%Q4'24$142.3M-5%Q1'25$134.5M
Activity profile
$ moved · Q1'25
New0%Increased100%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.6 years
<1Q0%1-4Q44%1-2Y11%2Y+44%

MSD Partners, L.P. manages $134.5M across 9 positions as of Q1 2025. Top holdings: ODD (57.3%), HAYW (13.9%), XPOF (10.3%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Q1 2025 Summary

Increased 2. Top move: EEX (INCREASED, conviction 82). Portfolio: $134M across 9 positions.

Top holdings by portfolio weight

Total AUM$134M
ODD57.31%
HAYW13.94%
XPOF10.25%
RNW9.16%
SAFE3.10%
EEX3.07%
OPITQ1.71%
TTAN1.30%
TLSI0.16%

Portfolio allocation by GICS sector

Sectors9
Consumer Defensive57.31%
Industrials13.94%
Consumer Cyclical10.25%
Utilities9.16%
Real Estate3.10%
Communication Services3.07%
Unknown1.71%
Technology1.30%
Healthcare0.16%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Consumer Defensive, Industrials, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L17
Conviction37
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used